Rationale:
Genome-wide association studies previously identified an association of rs9388451 at chromosome 6q22.3 (near
HEY2
) with Brugada syndrome. The causal gene and underlying mechanism remain unresolved.
Objective:
We used an integrative approach entailing transcriptomic studies in human hearts and electrophysiological studies in
Hey2
+/−
(
Hey2
heterozygous knockout) mice to dissect the underpinnings of the 6q22.31 association with Brugada syndrome.
Methods and Results:
We queried expression quantitative trait locus data acquired in 190 human left ventricular samples from the genotype-tissue expression consortium for
cis
-expression quantitative trait locus effects of rs9388451, which revealed an association between Brugada syndrome risk allele dosage and
HEY2
expression (β=+0.159;
P
=0.0036). In the same transcriptomic data, we conducted genome-wide coexpression analysis for
HEY2
, which uncovered
KCNIP2
, encoding the β-subunit of the channel underlying the transient outward current (
I
to
), as the transcript most robustly correlating with
HEY2
expression (β=+1.47;
P
=2×10
−34
). Transcript abundance of
Hey2
and the
I
to
subunits
Kcnip2
and
Kcnd2
, assessed by quantitative reverse transcription–polymerase chain reaction, was higher in subepicardium versus subendocardium in both left and right ventricles, with lower levels in
Hey2
+/−
mice compared with wild type. Surface ECG measurements showed less prominent J waves in
Hey2
+/−
mice compared with wild-type. In wild-type mice, patch-clamp electrophysiological studies on cardiomyocytes from right ventricle demonstrated a shorter action potential duration and a lower V
max
in subepicardium compared with subendocardium cardiomyocytes, which was paralleled by a higher
I
to
and a lower sodium current (
I
Na
) density in subepicardium versus subendocardium. These transmural differences were diminished in
Hey2
+/−
mice because of changes in subepicardial cardiomyocytes.
Conclusions:
This study uncovers a role of
HEY2
in the normal transmural electrophysiological gradient in the ventricle and provides compelling evidence that genetic variation at 6q22.31 (rs9388451) is associated with Brugada syndrome through a
HEY2
-dependent alteration of ion channel expression across the cardiac ventricular wall.